Jason Cole - 19 Aug 2022 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Reporting relationship: Chief Strategy & Financial Off
Issuer ticker: BLUE
Reported as of: 19 Aug 2022
Net transaction value: -$78,473
SEC form: 4
Accepted by SEC: 23 Aug 2022, 16:50:07 UTC
Prior SEC filing: 08 Aug 2022
Source filing: View source filing
Reporting owner signature: /s/ Helen C. Fu, Attorney-in-Fact

Key filing fact

Jason Cole filed Form 4 for bluebird bio, Inc. (BLUE) on 23 Aug 2022.

Key facts

This page summarizes Jason Cole's Form 4 filing for bluebird bio, Inc. (BLUE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 Aug 2022, 16:50.

Change

Previous filing in this sequence was filed on 08 Aug 2022.
Current net transaction value: -$78,473.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BLUE transaction

Common Stock

Sale

Transaction value: $78,473
Shares: -14,194
Change %: -7%
Price: $5.53
Shares after: 189,546
Date: 19 Aug 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.

Footnote F2

The range in prices for the transaction reported on this line was $5.48 to $5.77. The average weighted price was $5.5286. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.